美股市場個股詳情
CPRX Catalyst Pharmaceuticals
- 22.070
- -0.270-1.21%
收盤價 11/29 13:00 (美東)
- 22.200
- +0.130+0.59%
盤後 17:01 (美東)
26.32億總市值18.70市盈率TTM
22.625最高價21.900最低價55.43萬股成交量22.500今開22.340昨收1225.56萬成交額0.52%換手率35.03市盈率(靜)1.19億總股本24.27052周最高3.98市淨率23.38億流通值13.00052周最低--股息TTM1.06億流通股24.270歷史最高--股息率TTM3.25%振幅0.370歷史最低22.109平均價1股每手
關於Catalyst Pharmaceuticals公司
Catalyst Pharmaceuticals Inc是一家生物製藥公司。該公司專注於爲患有罕見、衰弱、慢性神經肌肉疾病和神經系統疾病的人開發創新療法並將其商業化。該公司供應Firdapse，一種專利形式的磷酸阿米吡啶片，用於治療Lambbert-eaton肌無力綜合症患者。
公司介紹
公司代碼CPRX
公司名稱Catalyst Pharmaceuticals
上市日期2006/11/08
發行價格6.00
成立日期2002
CEOMr. Richard J. Daly
所屬市場納斯達克
員工數量167
年結日12-31
公司地址355 Alhambra Circle,Suite 801
城市Coral Gables
省份佛羅里達州
國家美國
郵編33134
電話1-305-420-3200
董事高管
-
姓名
- 職務
- 年薪
-
Richard J. Daly
- Director, President and Chief Executive Officer
- 1407.69萬
-
Jeffrey Del Carmen
- Executive Vice President and Chief Commercial Officer
- 250.61萬
-
Dr. Steven R. Miller,PhD
- Executive Vice President, Chief Operating Officer and Chief Scientific Officer
- 340.47萬
-
Michael W. Kalb
- Executive Vice President, Chief Financial Officer and Principal Accounting Officer
- --
-
Dr. Gary Ingenito,M.D.,PhD
- Chief Medical and Regulatory Officer
- 237.14萬
-
Brian Elsbernd, J.D.
- Chief Compliance Officer and Chief Legal Officer
- --
-
Dr. Preethi Sundaram, PhD
- Chief Strategy Officer
- --
-
Patrick J. McEnany
- Non-Executive Chairman of the Board
- 214.65萬
-
Tamar Thompson
- Independent Director
- 61.04萬
-
Charles B. O'Keeffe
- Lead Independent Director
- 39.72萬
-
Donald A. Denkhaus
- Independent Director
- 37.62萬
-
Dr. David S. Tierney,M.D.
- Independent Director
- 37.10萬
-
Molly Harper
- Independent Director
- 36.31萬
分析
目標價預測
暫無數據
熱議
美股
綜合熱度
股票代碼
最新價
升跌幅
暫無數據